Gene therapy is currently being considered as a treatment modality for a variety of disorders including cancer, inherited diseases such as cystic fibrosis and alpha-1 antitrypsin deficiency, and human immunodeficiency virus infection. 1, 2 Initial emphasis has been placed primarily on safety, and secondarily on transfection efficacy. Cationic liposome-mediated gene transfer has emerged in both experimental and human trials as an attractive delivery system because of its reported safety and effectiveness both in vitro and in vivo. [3] [4] [5] Earlier studies had suggested that both the systemic and local administration of liposome:DNA complexes were safe and well tolerated. 6, 7 However, in recent years concern has arisen that DNA in general, and bacterial DNA in particular, can elicit an innate immune response. Structural differences in bacterial DNA appear to be recognized by the host innate immune system as an alternative signal for the presence of infection. 8, 9 Bacterial DNA and synthetic oligonucleotides derived from bacterial DNA and grown in E. coli can be as efficient as endotoxin in activating macrophages and dendritic cells, and in stimulating the release of proinflammatory cytokines such as tumor necrosis factor␣ (TNF␣).
acute phase proteins interleukin-6, amyloid A, amyloid P, and seromucoid were also increased (P Ͻ 0.05), and this response was seen in endotoxin-resistant (C3H/HeJ) mice. The inflammatory response associated with gene transfer increased the mortality and severity of experimentally induced sterile inflammation (pancreatitis). We conclude that systemic administration of cationic liposomes and plasmid DNA is associated with induction of the innate immune response which may exacerbate pre-existing inflammatory processes. Gene Therapy (2000) 7, 1425-1430.
icity in vitro and that plasmid DNA can elicit a proinflammatory response, we assessed the tissue and systemic inflammatory response following in vivo cationic liposome-mediated gene transfer in otherwise healthy animals, and in an acute inflammatory model of experimental pancreatitis.
Cationic liposomes (equimolar dimethyldioctadecylammonium bromide (DDAB) and dioleoylphosphatidylethanolamine (DOPE)) complexed with a plasmid containing the bacterial CAT reporter gene (pMP6-CAT) were administered by single intraperitoneal injection to otherwise healthy mice. Pancreas, liver, spleen, lungs, and serum from each animal were harvested at multiple time-points, and CAT expression determined. All organs possessed transient CAT expression for periods up to two weeks ( Figure 1 ) with the greatest activity observed 12 h after transfection. Within 72 h, expression had declined to less than 5% of peak levels and remained low but detectable thereafter for periods of up to 2 weeks.
To evaluate the pro-inflammatory response following successful cationic liposome-mediated gene transfer, TNF␣ and interleukin-1␤ (IL-1␤) gene expression were determined in each of these organs after a single intraperitoneal injection of liposomes and pMP6-CAT to otherwise healthy mice. Hepatic, pancreatic, splenic and pulmonary TNF␣ and IL-1␤ gene expression were determined 24 h after transfection. Pancreatic and hepatic TNF␣ and IL-1␤ mRNA were significantly increased compared with nontransfected animals (Figure 2 ). Although TNF␣ and IL-1␤ gene expression within the 14 
C chloramphenicol and n-butyrl coenzyme A, according to the manufacturer's instructions (Promega, Madison, WI, USA) The pancreas (b), spleen (), lungs (̆) and liver (᭺) were all transfected for the duration of the experiment (all time-points P Ͻ 0.05 versus nontransfected animals). Values represent the mean of four to eight animals per time-point.
spleen and lungs were increased, those levels did not reach statistical significance which may be due to the presence of some modest constitutive expression of TNF␣ and IL-1␤ mRNA within these organs in normal animals. Serum IL-1␤ and TNF␣ were not detectable in any of the mice after liposome and plasmid DNA administration.
To evaluate the systemic innate immune response to cationic liposome-mediated gene transfer in normal animals, serum interleukin-6 (IL-6), amyloid A (SAA), amyloid P (SAP) and seromucoid (SSM) were also determined. These proteins are accepted indicators of an hepatic acute phase protein response to injury and stress, 11 and plasma levels often correlate with the severity of the inflammatory stimulus. Transfected animals demonstrated a monophasic increase in all four serum markers peaking within 12-24 h with levels returning to normal within 3 days after transfection (Figure 3) .
Figure 2 Tumor necrosis factor alpha (TNF␣) and interleukin-1 beta (IL-
Since modest amounts of endotoxin were present in the plasmid preparation (1.1 to 4.4 EU/mg DNA) and are known to induce an acute phase response when administered, the studies were repeated in endotoxin-resistant C3H/HeJ mice. Liposome-mediated gene transfer resulted in a similar elevation of acute phase proteins in these mice (Figure 4) suggesting that the DNA and liposomes themeselves, and not contaminating endotoxin, were responsible for this inflammatory response. Since the functional mutation in the C3H/HeJ mouse which conveys resistance to endotoxin is in a CD14 and/or Toll-4 locus, 12 the findings suggest that the induction of an acute phase response by plasmid DNA and cationic liposomes is through cell-signaling pathways independent of CD14 and Toll-4.
To determine whether the plasmid DNA, liposomes or combinations of the two were responsible for the induction of the acute phase response, additional endotoxinresistant C3H/HeJ mice were administered either buffer alone, plasmid DNA or cationic liposomes in the buffer. Results were compared with mice that had received the plasmid DNA complexed to the liposomes (Table 1) . Not unexpectedly, administration of DNA alone recapitulated the increases in acute phase protein responses seen with the DNA complexed to the liposomes. However, administration of liposomes alone produced some, albeit variable, acute phase response in itself. Although plasma IL-6 and seromucoid levels were unaffected by liposome administration, amyloid A and amyloid P concentrations were increased, and amyloid A concentrations Gene Therapy
Figure 4 Markers of the systemic acute inflammatory response in endotoxin resistant mice (C3H/HeJ). Endotoxin-resistant C3H/HeJ mice (Jackson Laboratory, Bar Harbor, ME, USA) were transfected by the intraperitoneal administration of cationic liposomes and a reporter gene and killed 24 h later. Serum amyloid A (SAA), amyloid P (SAP) and seromucoid (SSM) were increased compared with nontransfected animals. Values represent the mean ± s.e.m. for at least eight mice at each time-point. Asterisks indicate difference from nontransfected at P Ͻ 0.01.
approached those seen following plasmid DNA administration.
The obvious question which arose from these initial findings was whether the inflammatory response to liposome-mediated gene transfer would be detrimental to the host if the transfection event occurred during experimentally induced inflammation. Previously, liposome and plasma-mediated gene transfer has been shown to be effective as a delivery system during acute inflammatory processes. 13, 14 Several groups have demonstrated that liposome and plasmid-mediated expression of either IL-10, soluble TNF receptors, COX-2, IL-4 or IL-11 could reduce the inflammatory consequences of endotoxin shock or caerulein-induced pancreatitis. [15] [16] [17] [18] However, these therapies were generally administered hours or days before the induction of experimental inflammation, and the resulting inflammatory response to the administered liposomes and plasmid DNA may have induced tolerance in these animals and contributed to the improved morbidity and mortality. The present study examined whether the inflammatory response to administered liposomes and plasmid DNA could affect the outcome during experimental inflammation.
Severe acute pancreatitis was induced in mice by feeding a choline-deficient ethionine-supplemented diet. 19 This diet is known to induce a sterile pancreatitis in which the lethality and overall severity is mediated by increased IL-1␤, TNF␣ and IL-6 expression within the pancreas, liver and lungs. 20, 21 Twenty-four hours after the induction of pancreatitis, animals received an intraperitoneal injection of Lactated Ringer's solution (nontransfected) or liposomes and pMP6-CAT. CAT activity within the pancreas, liver and lung was confirmed in animals administered liposomes and pMP6- Interleukin-6, pg/ml 9 ± 7 6 3 ± 41 0 ND Endotoxin-resistant C3H/HeJ mice recieved the intraperitoneal administration of buffer, plasmid DNA in the buffer or cationic liposomes alone, and were killed 24 h later. Serum amyloid A, amyloid P, and seromucoid were measured at 24 h and were compared with mice receiving the plasmid DNA and liposomes together (Figure 4) . a Difference from buffer alone at P Ͻ 0.05. b Difference from plasmid DNA. Samples were analyzed by one-way ANOVA with post-hoc testing performed with Fisher's least significant difference. ND, not determined.
CAT after the induction of pancreatitis (data not shown). Mortality was evaluated for 10 days after the induction of pancreatitis ( Figure 5 ), and a significant decrease in survival was observed in animals receiving liposomes and plasmid DNA compared with nontransfected animals. Transfected animals died earlier than nontransfected animals beginning approximately 36 h later, and this time-period correlates with the maximal increase in tissue and systemic inflammation previously demonstrated by cationic liposome-mediated gene transfer into otherwise normal animals ( Figures 2-4) . Pancreatitis severity was determined in a separate group of animals that received Lactated Ringer's solution or liposomes and pMP6-CAT 24 h after the induction of pancreatitis. Pancreatitis was present in all animals receiving the choline-deficient diet as evidenced by The combination of increased tissue TNF␣ and IL-1␤ mRNA as well as serum markers of inflammation (IL-6, serum amyloid A, serum amyloid P and seromucoid) in wild-type and endotoxin-resistant mice demonstrates that cationic liposome-mediated gene transfer induces a systemic inflammatory response in otherwise healthy mice which is not due to endotoxin. This inflammatory response to cationic liposome-mediated gene transfer exacerbated the mortality and increased the severity of experimentally induced sterile inflammation (acute pancreatitis). Scheule et al 22 have previously reported that cationic liposomes alone administered to murine lungs by nasal instillation during inspiration induce local pulmonary inflammation. In addition, other studies [23] [24] [25] have demonstrated that bacterial DNA itself, particularly DNA containing unmethylated CpG motifs, activates B cells and induces macrophage production of TNF␣ and IL-1␤. The current study, however, demonstrates that activation of the innate immune system and a systemic inflammatory response follows the administration of cationic liposomes and plasmid DNA. Furthermore, these results suggest that this inflammatory response can influence outcome in an experimental model of inflammation. As liposome-mediated gene transfer has been promulgated as a relatively safe and effective means to produce transient gene expression, this study proposes that the inherent inflammatory properties of this approach need to be considered when liposome and plasmid-based gene therapy is being employed. Modifying the composition of the plasmid DNA to reduce its inherent inflammatory properties, or coexpressing proteins that may modulate the innate immune response, are two potential approaches to reduce the inflammatory response and improve tolerance.
